Decelerated Neurodegeneration After Intravitreal Injection of Α-Synuclein Antibodies in a Glaucoma Animal Model

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-06702-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lowered Intraocular Pressure in a Glaucoma Patient After Intravitreal Injection of Ocriplasmin

Clinical Ophthalmology
Ophthalmology
2015English

Ocular Hypertension and Glaucoma After Intravitreal Injection of Triamcinolone Acetonide

Middle Black Sea Journal of Health Science
2018English

Intravitreal Injection of Β-Crystallin B2 Improves Retinal Ganglion Cell Survival in an Experimental Animal Model of Glaucoma

PLoS ONE
Multidisciplinary
2017English

Autonomic Ganglionic Injection of Α-Synuclein Fibrils as a Model of Pure Autonomic Failure Α-Synucleinopathy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Electroacupuncture Remediates Glial Dysfunction and Ameliorates Neurodegeneration in the Astrocytic Α-Synuclein Mutant Mouse Model

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2015English

Nrf2 Mitigates LRRK2- And Α-Synuclein–induced Neurodegeneration by Modulating Proteostasis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Vitreous Opacities After Intravitreal Triamcinolone Injection- A Case Report

BMC Ophthalmology
MedicineOphthalmology
2018English

The Role of Poly(ADP-Ribose) in Α-Synuclein Neurodegeneration: Another Piece of the Puzzle for Α-Synucleinopathies

Movement Disorders Clinical Practice
Neurology
2019English

Anterior Segment Changes Following Intravitreal Bevacizumab Injection for Treatment of Neovascular Glaucoma

Clinical Ophthalmology
Ophthalmology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy